Multiple Choice
MATCHING
-An enzyme that participates in the development of obesity
A) 2
B) 40
C) 70
D) 200-300
E) Intragastric balloon
F) Yo-yo dieting
G) Leptin
H) Phentermine
I) Ghrelin
J) Orlistat
K) Set point
L) White fat
M) Stomach
N) Brown fat
O) Brite adipocytes
P) Liposuction
Q) Underweight
R) Lipoprotein lipase
S) Spot reducing
T) Obesogenic environment
Correct Answer:
Verified
Correct Answer:
Verified
Q20: Which of the following statements accurately describes
Q21: In general,weight-loss diets need to provide a
Q22: MATCHING<br>-Percentage of underweight U.S.adults<br>A)2<br>B)40<br>C)70<br>D)200-300<br>E)Intragastric balloon<br>F)Yo-yo dieting<br>G)Leptin<br>H)Phentermine<br>I)Ghrelin<br>J)Orlistat<br>K)Set point<br>L)White
Q23: The prescription drug orlistat acts by _.<br>A) inhibiting
Q24: Discuss how fat cells develop in number
Q26: MATCHING<br>-Attempt to lose weight in "problem areas"
Q27: MATCHING<br>-Nicknamed the satiety hormone<br>A)2<br>B)40<br>C)70<br>D)200-300<br>E)Intragastric balloon<br>F)Yo-yo dieting<br>G)Leptin<br>H)Phentermine<br>I)Ghrelin<br>J)Orlistat<br>K)Set point<br>L)White
Q28: To maximize the long-term success of a
Q29: Improvements in physical capabilities and quality of
Q30: The study of the influence of environmental